Expression of L-type amino acid transporter 1 in various skin lesions

被引:9
作者
Hirano, Kazuhiko [1 ]
Uno, Kaname [2 ]
Kuwabara, Haruki [2 ]
Kojima, Kaoruko [1 ]
Ohno, Shin-ichiro [3 ]
Sakurai, Hiroyuki [4 ]
Kamma, Hiroshi [1 ]
Kurata, Atsushi [3 ]
机构
[1] Kyorin Univ, Sch Med, Dept Pathol, Tokyo, Japan
[2] Kyorin Univ, Sch Med, Tokyo, Japan
[3] Tokyo Med Univ, Dept Mol Pathol, Tokyo 1608402, Japan
[4] Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Tokyo, Japan
基金
日本学术振兴会;
关键词
L-type amino acid transporter 1; Seborrheic keratosis; Keratoacanthoma; Bowen's disease; Skin carcinoma; SQUAMOUS-CELL CARCINOMA; HEAVY-CHAIN; 4F2HC; PROGNOSTIC-SIGNIFICANCE; LUNG-CANCER; LAT1; TUMOR; KERATOACANTHOMA; GROWTH; KI-67; KERATOSIS;
D O I
10.1016/j.prp.2014.05.001
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
L-type amino acid transporter 1 (LAT1) is a Na+-independent neutral amino acid transporter that has an essential role in cell proliferation. Although the involvement of LAT1 in human carcinogenesis has been investigated by immunohistochemistry in various organs, LAT1 expression in skin has not been reported yet. Therefore, in the present study, immunohistochemistry for LAT1 was performed in 15 keratoacanthoma (KA), 10 seborrheic keratosis, 16 Bowen's disease, 11 basal cell carcinoma (BCC), and 9 squamous cell carcinoma (SCC) cases as well as 61 normal epidermis as control. It was demonstrated that LAT1 expression limited to the basal layer was occasionally observed in normal epidermis while its expression was significantly decreased in the epithelium of seborrheic keratosis and Bowen's disease (P<0.05). By contrast, a significantly higher rate of LAT1 expression was observed in the epithelium of KA, BCC, and SCC than in normal epidermis (P<0.05). Although LAT1 expression was limited to the basal layer or rim of the nests in KA, LAT1 expression was also observed in the center of the nests in BCC and SCC (P<0.001). Thus, LAT1 is differentially expressed in various skin lesions and may be an especially useful marker to distinguish KA from SCC. (C) 2014 Elsevier GmbH. All rights reserved.
引用
收藏
页码:634 / 639
页数:6
相关论文
共 31 条
[1]  
Apa DD, 2003, J EXP CLIN CANC RES, V22, P441
[2]   Gene expression profiles in T24 human bladder carcinoma cells by inhibiting an L-type amino acid transporter, LAT1 [J].
Baniasadi, Shadi ;
Chairoungdua, Arthit ;
Iribe, Yuji ;
Kanai, Yoshikatsu ;
Endou, Hitoshi ;
Aisaki, Ken-ichi ;
Igarashi, Katsuhide ;
Kanno, Jun .
ARCHIVES OF PHARMACAL RESEARCH, 2007, 30 (04) :444-452
[3]   Identification of an amino acid transporter associated with the cystinuria-related type II membrane glycoprotein [J].
Chairoungdua, A ;
Segawa, H ;
Kim, JY ;
Miyamoto, K ;
Haga, H ;
Fukui, Y ;
Mizoguchi, K ;
Ito, H ;
Takeda, E ;
Endou, H ;
Kanai, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (41) :28845-28848
[4]   Guidelines for management of Bowen's disease: 2006 update [J].
Cox, N. H. ;
Eedy, D. J. ;
Morton, C. A. .
BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (01) :11-21
[5]   Aging differentially affects human skeletal muscle amino acid transporter expression when essential amino acids are ingested after exercise [J].
Dickinson, Jared M. ;
Drummond, Micah J. ;
Coben, Jennifer R. ;
Volpi, Elena ;
Rasmussen, Blake B. .
CLINICAL NUTRITION, 2013, 32 (02) :273-280
[6]   The nuclear factor kappa B p50 subunit and cortactin as markers to distinguish between keratoacanthoma and well-differentiated squamous cell carcinoma [J].
Fujii, M. ;
Honma, M. ;
Takahashi, H. ;
Ishida-Yamamoto, A. ;
Iizuka, H. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2011, 36 (07) :788-792
[7]  
GERDES J, 1984, J IMMUNOL, V133, P1710
[8]   L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer [J].
Imai, Hisao ;
Kaira, Kyoichi ;
Oriuchi, Noboru ;
Yanagitani, Noriko ;
Sunaga, Noriaki ;
Ishizuka, Tamotsu ;
Kanai, Yoshikatsu ;
Endou, Hitoshi ;
Nakajima, Takashi ;
Mori, Masatomo .
HISTOPATHOLOGY, 2009, 54 (07) :804-813
[9]   Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer [J].
Kaira, K. ;
Oriuchi, N. ;
Imai, H. ;
Shimizu, K. ;
Yanagitani, N. ;
Sunaga, N. ;
Hisada, T. ;
Tanaka, S. ;
Ishizuka, T. ;
Kanai, Y. ;
Endou, H. ;
Nakajima, T. ;
Mori, M. .
BRITISH JOURNAL OF CANCER, 2008, 98 (04) :742-748
[10]   Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma [J].
Kaira, Kyoichi ;
Oriuchi, Noboru ;
Imai, Hisao ;
Shimizu, Kimihiro ;
Yanagitani, Noriko ;
Sunaga, Noriaki ;
Hisada, Takeshi ;
Ishizuka, Tamotsu ;
Kanai, Yoshikatsu ;
Nakajima, Takashi ;
Mori, Masatomo .
LUNG CANCER, 2009, 66 (01) :120-126